Tolera Therapeutics tolera.com


Public lists: Pharma Startups (4732)

Tolera Therapeutics is developing targeted therapies for immune suppression and immune tolerance, designed for use in organ transplant surgeries and other medical settings requiring safer, more targeted immune modulation. The goal is to provide improved induction therapy with a better safety profile than current treatment options. The company's technology, which stems from organ transplant research done at the Cleveland Clinic, has been undergoing clinical research and has been tested in humans....Show all

Tolera Therapeutics is developing targeted therapies for immune suppression and immune tolerance, designed for use in organ transplant surgeries and other medical settings requiring safer, more targeted immune modulation. The goal is to provide impro...Show all

Company (Alive / Active)

Phone: 269-585-2100

Fax:

350 East Michigan Avenue
Suite 205
Kalamazoo, 49007
Michigan, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Tolera Therapeutics $24.2M Sep 17, 2014
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Tolera Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 9 investors

Competitors

Company Status Description Investors

ARYX Therapeutics

Fremont, California, United States
IPO / Went publicARYx Therapeutics is a privately-held pharmaceutical research and development company focused on addressing safety concerns in well-established and commercially successful existing therapies through application of its proprietary ARYx RetroMetabolic (ARM) drug design. ARYx improves today's drugs, making proven therapies safer. ARYx currently has three products in clinical trials. For more information, please see the company's web site at www.aryx.com.Login to see details

Trillium Therapeutics

Toronto, Ontario, Canada
IPO / Went publicTrillium Therapeutics is a research and development company developing therapies that restore balance to the immune system in conditions associated with aberrant and harmful immune responses, including autoimmune and inflammatory disorders, graft rejection, cancer and chronic viral diseases.Login to see details
See all 16 competitors

Patents